Labcorp Launches Neutralizing Antibody Test

Published on: 

Applied Clinical Trials

LabCorp has announced the launch of a new test that can be used to assess the capacity of antibodies in patient plasma to inhibit the SARS-CoV-2 virus. This neutralizing antibody test will be available to biopharmaceutical companies, hospitals, blood banks and other plasma-screening facilities. 

For more information, click here.